magazinelogo

Advances in Computer and Communication

ISSN Online: 2767-2875 CODEN: ACCDC3
Frequency: quarterly Email: acc@hillpublisher.com
Total View: 1358164 Downloads: 282259 Citations: 204 (From Dimensions)
ArticleOpen Access http://dx.doi.org/10.26855/acc.2026.09.015

Ensemble-learning-based Predictor for Anticancer Peptide Identification Using Multi-view Sequence Features

Xiaoqin Fan*, Xin Zhang, Mingxing Xu, Kexu Wu

Suqian University, Suqian 223800, Jiangsu, China.

*Corresponding author: Xiaoqin Fan

Published: September 21, 2026

Abstract

Anticancer peptides (ACPs) hold considerable promise as therapeutic agents, but screening candidate peptides in the laboratory is both expensive and slow, so reliable computational tools are in demand. A number of machine-learning and deep-learning predictors already exist, yet their accuracy on small benchmark datasets is still modest, and the benefit of merging different sequence descriptors has not been fully exploited. This paper describes an ensemble-learning workflow for identifying ACPs that draws on multiple complementary views of each sequence. Each peptide is first represented by amino acid composition (AAC) and composition of k-spaced amino acid pairs (CKSAAP), which jointly capture overall composition and local order; two physicochemical attributes (average charge and average hydrophobicity) are appended to these features. The resulting 822 dimensions are Z-score standardized and then pruned to 262 informative features by an XGBoost-based selector. Prediction is made by a soft-voting ensemble that pools a Random Forest and a tuned XGBoost classifier. Evaluated on the ACP-2.0 benchmark, this ensemble reaches 77.5% accuracy, a Matthews correlation coefficient of 0.551, and an area under the ROC curve (AUC) of 0.850, beating both base learners and the AntiCP 2.0 baseline while staying competitive with deep-learning methods that are far more demanding computationally. The results point to a practical, accurate tool for large-scale ACP screening.

Keyword

Anticancer peptides; ensemble learning; multi-view feature; XGBoost; random forest; soft voting

References

[1] Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2022: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229-63. 

[2] Ghadiri N, Zali H, Vafaei M, et al. Bioactive peptides: An alternative therapeutic approach for cancer management. Front Immunol. 2024;15:1310443. 

[3] Xu M, Li W, Wang X, et al. Integrating traditional machine learning and deep learning for precision screening of anticancer peptides: A novel approach for efficient drug discovery. ACS Omega. 2024;9(14):16820-31. 

[4] Kim H, Kim J, Lee I. Artificial intelligence in drug discovery: A comprehensive review of data-driven and machine learning approaches. Biotechnol Bioprocess Eng. 2020;25(6):895-930. 

[5] Schaduangrat N, Lohavanichbutr P, Saeaeung A, et al. Acpred: A computational tool for the prediction and analysis of anticancer peptides. Molecules. 2019;24(10):1973. 

[6] Ahmed S, Mugal I, Ijaz MT, et al. Acp-Mhcnn: An accurate multi-headed deep-convolutional neural network to predict anticancer peptides. Sci Rep. 2021;11:23676. 

[7] Yi HC, You ZH, Huang DS, et al. Acp-Dl: A deep learning long short-term memory model to predict anticancer peptides using high-efficiency feature representation. Mol Ther Nucleic Acids. 2019;17:1-9. 

[8] Chiangjong W, Chutipongtanate S, Hongeng S. Anticancer peptide: Physicochemical property, functional aspect and trend in clinical application. Int J Oncol. 2020;57(3):678-96. 

[9] Van Hilten A, Chevyrev V, Maticzka D, et al. Designing interpretable deep learning applications for functional genomics: A quantitative analysis. Brief Bioinform. 2024;25(5):bbae344. 

[10] Yuan Q, Chen J, Zhao H, et al. Prediction of anticancer peptides based on an ensemble model of deep learning and machine learning using ordinal positional encoding. Brief Bioinform. 2023;24(1):bbac630. 

[11] Agrawal P, Bhalla S, Chaudhary K, et al. Anticp 2.0: An updated model for predicting anticancer peptides. Brief Bioinform. 2021;22(3):bbaa411. 

[12] Zheng B, Chen J, Zhu X, et al. Iacp-Sei: An anticancer peptide identification method incorporating sequence evolutionary information. J Data Sci Intell Syst. 2025;3(1):45-58. 

[13] Huang G, Liu X, Li Y, et al. Acp-Dpe: A dual-channel deep learning model for anticancer peptide prediction. IET Syst Biol. 2025;19(1):e70010. 

[14] Yao L, You ZH, Huang DS. Acp-Capspred: An explainable computational framework for identification and functional prediction of anticancer peptides based on capsule network. Brief Bioinform. 2024;25(5):bbae380.

Copyright

© 2026 by the author(s).
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial-NoDerivatives (CC BY-NC-ND) license, which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited and is not modified or adapted.
https://creativecommons.org/licenses/by-nc-nd/4.0/

How to cite this paper

Ensemble-learning-based Predictor for Anticancer Peptide Identification Using Multi-view Sequence Features

How to cite this paper: Xiaoqin Fan, Xin Zhang, Mingxing Xu, Kexu Wu. (2026) Ensemble-learning-based Predictor for Anticancer Peptide Identification Using Multi-view Sequence Features. Advances in Computer and Communication, 7(3), 187-191.

DOI: http://dx.doi.org/10.26855/acc.2026.09.015